.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Farmers Insurance
Baxter
Federal Trade Commission
Julphar
Harvard Business School
Teva
US Department of Justice
Johnson and Johnson
Chinese Patent Office

Generated: December 12, 2017

DrugPatentWatch Database Preview

Reserpine; trichlormethiazide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for reserpine; trichlormethiazide and what is the scope of reserpine; trichlormethiazide freedom to operate?

Reserpine; trichlormethiazide
is the generic ingredient in four branded drugs marketed by Sanofi Aventis Us, Schering, and Watson Labs, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for reserpine; trichlormethiazide.

Summary for reserpine; trichlormethiazide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis UsMETATENSIN #4reserpine; trichlormethiazideTABLET;ORAL012972-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
ScheringNAQUIVALreserpine; trichlormethiazideTABLET;ORAL012265-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sanofi Aventis UsMETATENSIN #2reserpine; trichlormethiazideTABLET;ORAL012972-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsTRICHLORMETHIAZIDE W/ RESERPINEreserpine; trichlormethiazideTABLET;ORAL085248-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Teva
QuintilesIMS
Cipla
Moodys
Baxter
McKesson
Cerilliant
Federal Trade Commission
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot